Ms Jennifer Insley-Pruitt > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Dechert LLP
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Ms Jennifer Insley-Pruitt
+1 212 698 3500 jennifer.insley-pruitt@dechert.com
Work Department
Intellectual Property
Position
Partner
Career
Jennifer Insley-Pruitt focuses her practice on intellectual property counseling, enforcement, and infringement disputes. She has represented clients across a variety of industries, including financial services, fashion, entertainment, technology, consumer goods, and health care. She has experience in litigation in federal and state court and before the Trademark Trial and Appeal Board, trademark and copyright clearance and prosecution, and the acquisition, sale, and licensing of intellectual property rights.
Education
- The University of Chicago, B.A., 2001, Phi Beta Kappa, Student Marshal, J. William Fulbright fellowship awarded for post-graduate study
- University of Pennsylvania, M.A., 2005, Jacob K. Javits Fellowship; Andrew W. Mellon Fellowship in Humanistic Studies
- New York University School of Law, J.D., 2008, Editor-in-Chief, Journal of International Law and Politics; Robert McKay Scholar; Dean’s Scholarship
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation